Inari Medical Inc
NASDAQ:NARI
Intrinsic Value
Inari Medical, Inc. operates as a medical device company. [ Read More ]
The intrinsic value of one NARI stock under the Base Case scenario is 26.44 USD. Compared to the current market price of 38.64 USD, Inari Medical Inc is Overvalued by 32%.
Valuation Backtest
Inari Medical Inc
Run backtest to discover the historical profit from buying and selling NARI stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Inari Medical Inc
Current Assets | 235.6m |
Cash & Short-Term Investments | 115.5m |
Receivables | 70.1m |
Other Current Assets | 50m |
Non-Current Assets | 438.7m |
Long-Term Investments | 1.5m |
PP&E | 69.3m |
Intangibles | 365.2m |
Other Non-Current Assets | 2.6m |
Current Liabilities | 76.3m |
Accounts Payable | 10.6m |
Accrued Liabilities | 65.8m |
Non-Current Liabilities | 133m |
Other Non-Current Liabilities | 133m |
Earnings Waterfall
Inari Medical Inc
Revenue
|
493.6m
USD
|
Cost of Revenue
|
-59.1m
USD
|
Gross Profit
|
434.6m
USD
|
Operating Expenses
|
-438.2m
USD
|
Operating Income
|
-3.6m
USD
|
Other Expenses
|
2m
USD
|
Net Income
|
-1.6m
USD
|
Free Cash Flow Analysis
Inari Medical Inc
What is Free Cash Flow?
NARI Profitability Score
Profitability Due Diligence
Inari Medical Inc's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
Score
Inari Medical Inc's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
NARI Solvency Score
Solvency Due Diligence
Inari Medical Inc's solvency score is 65/100. The higher the solvency score, the more solvent the company is.
Score
Inari Medical Inc's solvency score is 65/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
NARI Price Targets Summary
Inari Medical Inc
According to Wall Street analysts, the average 1-year price target for NARI is 74.65 USD with a low forecast of 47.47 USD and a high forecast of 105 USD.
Ownership
NARI Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
NARI Price
Inari Medical Inc
Average Annual Return | 25.69% |
Standard Deviation of Annual Returns | 69.39% |
Max Drawdown | -69% |
Market Capitalization | 2.2B USD |
Shares Outstanding | 57 960 600 |
Percentage of Shares Shorted | 8.73% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Inari Medical, Inc. operates as a medical device company. The company is headquartered in Irvine, California and currently employs 800 full-time employees. The company went IPO on 2020-05-22. The firm operates through the development and commercialization of invasive mechanical thrombectomy devices to treat thromboembolism in the venous system. Its product offerings consist of two minimally invasive, catheter-based mechanical thrombectomy systems, which are for venous system and the treatment of the two distinct manifestations of venous thromboembolism (VTE), deep vein thrombosis (DVT), and pulmonary embolism (PE). The Company’s products include ClotTriever System, FlowTriever System, FlowSaver, FlowStasis and FlowTriever 2. The ClotTriever system is a mechanical thrombectomy system designed to core, capture and remove large clots from large vessels and is used to treat DVT and its components include ClotTriever Catheter and ClotTriever Sheath. The FlowTriever is a large bore catheter-based aspiration and mechanical thrombectomy system designed to remove large clots from large vessels to treat PE.
Contact
IPO
Employees
Officers
The intrinsic value of one NARI stock under the Base Case scenario is 26.44 USD.
Compared to the current market price of 38.64 USD, Inari Medical Inc is Overvalued by 32%.